Principles of Drug Design

Similar documents
Principles of Drug Design

In silico pharmacology for drug discovery

CH MEDICINAL CHEMISTRY

Early Stages of Drug Discovery in the Pharmaceutical Industry

Structural biology and drug design: An overview

Introduction to Chemoinformatics and Drug Discovery

Fondamenti di Chimica Farmaceutica. Computer Chemistry in Drug Research: Introduction

Plan. Day 2: Exercise on MHC molecules.

The Practice of Medicinal Chemistry

FRAUNHOFER IME SCREENINGPORT

Receptor Based Drug Design (1)

ENERGY MINIMIZATION AND CONFORMATION SEARCH ANALYSIS OF TYPE-2 ANTI-DIABETES DRUGS

Ping-Chiang Lyu. Institute of Bioinformatics and Structural Biology, Department of Life Science, National Tsing Hua University.

Energy Transformation, Cellular Energy & Enzymes (Outline)

EMPIRICAL VS. RATIONAL METHODS OF DISCOVERING NEW DRUGS

ENZYME KINETICS. Medical Biochemistry, Lecture 24

Chapter 8: An Introduction to Metabolism

CHEMISTRY (CHE) CHE 104 General Descriptive Chemistry II 3

Enzyme Enzymes are proteins that act as biological catalysts. Enzymes accelerate, or catalyze, chemical reactions. The molecules at the beginning of

Molecular Dynamics Graphical Visualization 3-D QSAR Pharmacophore QSAR, COMBINE, Scoring Functions, Homology Modeling,..

Membranes 2: Transportation

Ch 4: Cellular Metabolism, Part 1

Enzyme Reactions. Lecture 13: Kinetics II Michaelis-Menten Kinetics. Margaret A. Daugherty Fall v = k 1 [A] E + S ES ES* EP E + P

Michaelis-Menten Kinetics. Lecture 13: Kinetics II. Enzyme Reactions. Margaret A. Daugherty. Fall Substrates bind to the enzyme s active site

Biochemistry 3100 Sample Problems Binding proteins, Kinetics & Catalysis

Docking. GBCB 5874: Problem Solving in GBCB

C a h p a t p e t r e r 6 E z n y z m y e m s

MM-GBSA for Calculating Binding Affinity A rank-ordering study for the lead optimization of Fxa and COX-2 inhibitors

FUNDAMENTALS of SYSTEMS BIOLOGY From Synthetic Circuits to Whole-cell Models

Retrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a

Chapter 8: An Introduction to Metabolism

pharmaceutical industry- drug discovery

Drug Discovery. Zainab Al Kharusi Office: 33-10

Softwares for Molecular Docking. Lokesh P. Tripathi NCBS 17 December 2007

Chapter 6~ An Introduction to Metabolism

Biological Chemistry and Metabolic Pathways

Molecular Mechanics, Dynamics & Docking

Introduction to FBDD Fragment screening methods and library design

BA, BSc, and MSc Degree Examinations

5. Kinetics of Allosteric Enzymes. Sigmoidal Kinetics. Cooperativity Binding Constant

Synthetic organic compounds

Molecular Interactions F14NMI. Lecture 4: worked answers to practice questions

Molecular Simulation II. Classical Mechanical Treatment

Discussion Exercise 5: Analyzing Graphical Data

Syllabus BINF Computational Biology Core Course

CHEM 4170 Problem Set #1

Chapter 8. Enzymes: basic concept and kinetics

Describe how proteins and nucleic acids (DNA and RNA) are related to each other.

A primer on pharmacology pharmacodynamics

Computational Chemistry in Drug Design. Xavier Fradera Barcelona, 17/4/2007

JCICS Major Research Areas

Protein structure based approaches to inhibit Plasmodium DHODH for malaria

Chapter 8: An Introduction to Metabolism

An Introduction to Metabolism

Science Textbook and Instructional Materials Correlation to the 2010 Biology Standards of Learning and Curriculum Framework. Publisher Information

Chapter 5. Energy Flow in the Life of a Cell

Advanced Higher Biology. Unit 1- Cells and Proteins 2c) Membrane Proteins

BIOCHEMISTRY/MOLECULAR BIOLOGY

Previous Class. Today. Cosubstrates (cofactors)

Lecture 27. Transition States and Enzyme Catalysis

Energy, Enzymes, and Metabolism. Energy, Enzymes, and Metabolism. A. Energy and Energy Conversions. A. Energy and Energy Conversions

Cheminformatics platform for drug discovery application

MEDICINAL CHEMISTRY Homework 2 - ANSWERS

Chapter 10: Hemoglobin

Bio 101 General Biology 1

Plan. Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics.

Ground Rules of Metabolism CHAPTER 6

TRAINING REAXYS MEDICINAL CHEMISTRY

Toxicological Targets. Russell L. Carr Department of Basic Sciences College of Veterinary Medicine

FACULTY OF PHARMACY. M. Pharmacy I Semester (Suppl.) Examination, November 2015 (Common To All) Subject: Pharmaceutical Analytical Techniques

Two requirements for life: Self-replication and appropriate catalysis. A. Most enzymes (def.: biological catalysts) are proteins

5.1. Hardwares, Softwares and Web server used in Molecular modeling

ADVANCED PLACEMENT BIOLOGY

COMPUTER AIDED DRUG DESIGN (CADD) AND DEVELOPMENT METHODS

Level IV Course Units Offered by The Department of Chemistry For Special Degree in Computational Chemistry

Introduction and. Properties of Enzymes

Chapter 8: An Introduction to Metabolism

[Urea] (M) k (s -1 )

2013 W. H. Freeman and Company. 6 Enzymes

MOLECULAR DRUG TARGETS

Effect of Temperature Increasing the temperature increases the energy in the system. Two effects kinetic. denaturing

Energy Transformation and Metabolism (Outline)

RATIONAL DRUG DESIGN

2054, Chap. 8, page 1

Virginia Western Community College BIO 101 General Biology I

Dynamic Combinatorial Chemistry in the identification of new host guest interactions: proof of principle

Science Online Instructional Materials Correlation to the 2010 Biology Standards of Learning and Curriculum Framework

Patrick: An Introduction to Medicinal Chemistry 5e Chapter 03

Problem Set 5 Question 1

Bioisosteres in Medicinal Chemistry

BCMB 3100 Chapters 6,7,8 Enzyme Basics. Six Classes (IUBMB) Kinetics Michaelis-Menten Equation Vo, Km, Vmax, Kcat Lineweaver-Burk Plot

Computational chemical biology to address non-traditional drug targets. John Karanicolas

PET Tracer Kinetic Modeling In Drug

Structure-Based Drug Discovery An Overview

Biochemistry 462a - Enzyme Kinetics Reading - Chapter 8 Practice problems - Chapter 8: (not yet assigned); Enzymes extra problems

Structural Bioinformatics (C3210) Molecular Docking

ENZYMES. by: Dr. Hadi Mozafari

Quantitative structure activity relationship and drug design: A Review

CHEM 251 (4 credits): Description

Biochemistry Enzyme kinetics

Transcription:

Advanced Medicinal Chemistry II Principles of Drug Design Tentative Course Outline Instructors: Longqin Hu and John Kerrigan Direct questions and enquiries to the Course Coordinator: Longqin Hu I. Introduction to The Drug Discovery/Development (Hu) 1 lecture A. Drug Discovery 1. Definition of Drug Discovery 2. Stages of drug discovery 3. Strategic Issues in drug discovery B.. Drug Development 1. Chemistry 2. Preclinical Studies 3. Transition from Preclinical to Clinical 4. Planning the Drug Development Process 5. Clinical Research C.. Source of Drugs 1. Drugs from Natural Sources (Natural Products) a. Plants b. Animals c. Microorganisms (Fungi, Bacteria) 2. Drugs from Organic Synthesis II. Approaches to New Drug Discovery (Hu) 2 lectures A. Drugs Derived from Natural Products B. Existing Drugs as a Source for New Drug Discovery C. Using Disease Models as Screens for New Drug Leads D. Physiological Mechanisms: the Modern Rational Approach to Drug Design E: Approaches to Lead Optimization 1. Bioisosteric replacement 2. Conformation restriction a. Increase selectivity b. Increase affinity 3. Pharmacophore 4. Molecular dissection 5. Metabolic stabilization

Course Outline Page 2 III. The Chemistry of Drug Absorption, Distribution, Metabolism and Elimination: Issues Related to Drug Development (Hu) 2 lectures A. Administration and Absorption 1. Form of Drug 2. Routes of Administration 3. Models of Absorption Passive and Facilitated Thermodynamics and Kinetics 4. Bioavailability B. Drug Distribution 1. Physiological compartments 2. Protein binding C. Drug Metabolism Biotransformation (Brief Review) 1. Site of metabolism 2. Chemistry of phase I Metabolism 3. Chemistry of phase II Metabolism 4. Consequences of Metabolism 5. Metabolic inhibition and induction D. Elimination 1. Lungs 2. Kidney 3. Biliary excretion IV. Pharmacomodulation (Hu) 1 lecture A. Introduction and Rationale B. Increased Chemical Stability C. Altered Solubility D. Improved Taste and Compliance E. Increased Absorption F. Decreased Metabolism G. Increased Selectivity H. Enhanced protein binding I. Enhanced BBB penetration J. Tissue-specific distribution V. Enzymes as Targets of Drug Design (Hu) 4 lectures A. Enzyme kinetics 1. The Michaelis-Mention Equation 2. Steady state of an enzyme-catalyzed reaction 3. Validity of the Steady-state assumption

Course Outline Page 3 4. Graphs of the Michaelis-Mention Equation 5. Practical aspects of kinetic studies B. Enzyme inhibition and activation 1. Reversible and irreversible inhibition 2. Linear inhibition 3. Plotting inhibition results 4. Inhibition by a competing substrate 5. Enzyme activation C. Approaches to the Rational Design of Enzyme Inhibitors 1. Transition state analogues 2. Mechanism-based inhibitors 3. Affinity labels VI. Receptors as Targets of Drug Design (Hu) 3 lectures A. Receptor Theory B. Receptor Complexes and Allosteric Modulators C. Second and Third Messenger Systems D. Molecular Biology of Receptors F. Receptor Models and Nomenclature G. Receptor Binding Assays H. Lead Compound Discovery of Receptor agonists and antagonists 1. Natural Product Sources 2. Pharmacophore-based Ligand Libraries 3. Diversity-based ligand libraries 4. High-throughput screening VII. Design of Peptidomimetics (Hu) 1 lecture A. Limitations of Peptides as Drugs B. Cyclization of Peptides C. Constrained Amino Acids D. Molecular Mimics for Secondary Structures E. Amide Bond Isosteres F. Nonpeptide Ligands for Peptinergic Receptors VIII. Computer-Aided Drug Design (Kerrigan) 10 lectures A. Molecular Mechanics Force Fields 1. Introduction 2. MM2/MM3/MM4 force fields 3. CFF93 force field 4. AMBER 5. CHARMM (BIO+)

Course Outline Page 4 6. OPLS 7. ECEPP 8. The Merck force field (MMFF94) 9. Advantages and Disadvantages of the force field methods B. Solvation Effects in Molecular Mechanics 1. Introduction 2. Molecular solvent models 3. Continuum solvent models a. Surface area based b. Poisson-Boltzmann c. The GB/SA continuum model 4. Model comparison C. Minimization techniques 1. Simplex method 2. Line searching 3. Steepest descent 4. Conjugate gradient 5. Full matrix Newton-Raphson 6. Block diagonal Newton Raphson 7. Saddle Point search 8. Cerjan-Miller algorithm D. Conformational Analysis 1. Grid Search 2. Monte Carlo 3. Global minimum search 4. Macrocycles 5. Complexes & docking 6. Symmetry E. Binding Free Energy Calculation 1. Direct calculation 2. Calculation of Interaction Energies (Halgren s Method) 3. Multidimensional Monte Carlo integration F. Case Study(ies)/Applications 1. Conformational Analysis of substrate-macromolecule complexes 2. Deriving and using 3-dimensional pharmacophores 3. Structure-based methods to identify new lead compounds 4. De novo ligand design 5. Molecular similarity 6. QSAR

Course Outline Page 5 IX. Combinatorial Chemistry (Kerrigan) 4 lectures A. Introduction: Concepts and Terms B. Solid-phase Strategies 1. General Strategies and Concepts 2. Specific Implementation Issues a. Solid support b. Anchoring chemistry c. Coupling chemistry d. Protection schemes e. Analytical methods C. Solution Phase Strategies D. High Throughput Screening